Related Experiment Video
Updated: Feb 12, 2026

Live Imaging of Drug Responses in the Tumor Microenvironment in Mouse Models of Breast Cancer
Published on: March 24, 2013
Beyond Tissue Stiffness and Bioadhesivity: Advanced Biomaterials to Model Tumor Microenvironments and Drug Resistance
Ankur Singh1, Ilana Brito2, Jan Lammerding3
1Nancy E. and Peter C. Meinig School of Biomedical Engineering, Cornell University, Ithaca, NY, USA; Sibley School of Mechanical and Aerospace Engineering, Cornell University, Ithaca, NY, USA; Caryl and Israel Englander Institute for Precision Medicine, New York Presbyterian Hospital-Weill Cornell Medicine, New York, NY, USA.
Abstract:
Resistance to chemotherapy and pathway-targeted therapies poses a major problem in cancer research. While the fields of tumor biology and experimental therapeutics have already benefited from ex vivo preclinical tissue models, these models have yet to address the reasons for malignant transformations and the emergence of chemoresistance. With the increasing number of ex vivo models poised to incorporate physiological biophysical properties, along with the advent of genomic sequencing information, there are now unprecedented opportunities to better understand tumorigenesis and to design therapeutic approaches to overcome resistance. Here we discuss that new preclinical ex vivo models should consider - in addition to common biophysical parameters such as matrix stiffness and bioadhesivity - a more comprehensive milieu of tissue signaling, nuclear mechanics, immune response, and the gut microbiome.
Insights
New preclinical models are crucial for understanding cancer development and chemoresistance. Advanced ex vivo models incorporating tissue signaling, nuclear mechanics, and the gut microbiome offer unprecedented opportunities for therapeutic design.
Area of Science:
- Oncology
- Cancer Research
- Experimental Therapeutics
Background:
- Chemotherapy and targeted therapies face significant challenges due to cancer resistance.
- Ex vivo preclinical tissue models have advanced tumor biology but not fully addressed malignant transformation and chemoresistance.
- Genomic sequencing and advanced ex vivo models offer new avenues for understanding cancer.
Purpose of the Study:
- To highlight the limitations of current ex vivo models in addressing cancer resistance.
- To propose a more comprehensive approach for developing next-generation ex vivo models.
- To leverage new models for understanding tumorigenesis and overcoming therapeutic resistance.
Main Methods:
- Discussion of limitations in current ex vivo models.
- Identification of key biological and physical parameters for improved models.
- Integration of genomic data with advanced tissue engineering.
Main Results:
- Current ex vivo models do not adequately capture the complexity of cancer development and resistance.
- A comprehensive milieu including tissue signaling, nuclear mechanics, immune response, and gut microbiome is essential.
- Advanced ex vivo models can provide unprecedented opportunities for therapeutic design.
Conclusions:
- Next-generation ex vivo models must incorporate a broader range of physiological and biological factors.
- Improved models are critical for a deeper understanding of tumorigenesis and chemoresistance.
- This approach will facilitate the design of more effective cancer therapies.
More Related Videos
10:23Author Spotlight: Computing the Effects of a Local Radiofrequency Hyperthermia Intervention on Tumor Biomechanics
Published on: December 1, 2023
10:13A Brain Tumor/Organotypic Slice Co-culture System for Studying Tumor Microenvironment and Targeted Drug Therapies
Published on: November 7, 2015
Related Concept Videos
The Tumor Microenvironment
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Drug Distribution: Tissue Binding
For...
Resistivity
Resistance
Factors Affecting Drug Distribution: Tissue Permeability
Small molecules with a molecular weight below 500 to 600 Daltons can easily pass through the capillary membrane, gaining access to different tissues. Larger...